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Introduction
Nonallelic variants of histone H1 in metazoans share a common 
tripartite structure, with a conserved globular domain flanked 
by a short N-terminal domain and a longer C-terminal domain 
(CTD). FRAP analyses of cells expressing H1-GFP fusions have 
revealed that H1 variants bind chromatin dynamically in vivo 
and that both the globular domain and CTD contribute to chro-
matin binding (Lever et al., 2000; Misteli et al., 2000; Hendzel 
et al., 2004; Brown et al., 2006). H1-binding dynamics affect 
the chromatin access of high mobility group proteins, MeCP2 
(methyl-CpG–binding protein), upstream-binding factor (UBF), 
the glucocorticoid receptor, and other regulators by modulat-
ing H1-mediated chromatin folding and by enabling factors to 
compete with H1 for chromatin-binding sites (Zlatanova et al., 
2000; Phair et al., 2004; Bustin et al., 2005).
CTD interactions with linker DNA are important for higher 
order folding of chromatin (Allan et al., 1980, 1986; Bednar   
et al., 1998; Carruthers et al., 1998; Lu et al., 2009). S/TPXK/R 
Cdk substrate motifs that are repeated in the CTD contribute to 
its DNA binding (Suzuki, 1989; Vila et al., 2001; Roque et al., 
2005), and phosphorylation at these motifs affects CTD–DNA 
interactions (Roque et al., 2008). These motifs are phosphory-
lated to varying degrees in H1 prepared from asynchronous or   
mitosis-arrested mammalian cells (Garcia et al., 2004; Sarg et al., 
2006; Wisniewski et al., 2007), but how this affects chromatin 
processes is unclear. Analyses of synchronized cells suggest 
that H1 phosphorylation increases progressively during interphase 
before peaking transiently during mitosis (Gurley et al., 1975; 
Ajiro et al., 1981a,b), but few details are known about the site 
specificity of phosphorylation during interphase and mitosis be-
cause phosphorylation sites were not identified in these early 
analyses. Site-specific phosphorylation of an H1 variant during 
H
istone H1 phosphorylation affects chromatin con-
densation and function, but little is known about 
how specific phosphorylations impact the func-
tion of H1 variants in higher eukaryotes. In this study, we 
show that specific sites in H1.2 and H1.4 of human cells 
are phosphorylated only during mitosis or during both 
mitosis and interphase. Antisera generated to individual 
H1.2/H1.4 interphase phosphorylations reveal that they 
are distributed throughout nuclei and enriched in nucleoli. 
Moreover, interphase phosphorylated H1.4 is enriched 
at active 45S preribosomal RNA gene promoters and is 
rapidly induced at steroid hormone response elements 
by hormone treatment. Our results imply that site-specific   
interphase H1 phosphorylation facilitates transcription by 
RNA polymerases I and II and has an unanticipated func-
tion in ribosome biogenesis and control of cell growth. 
Differences in the numbers, structure, and locations of 
interphase phosphorylation sites may contribute to the 
functional diversity of H1 variants.
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consistent with previous analyses of H1 phosphorylation stoi-
chiometry in synchronized cells (Ajiro et al., 1981a,b; Gurley   
et al., 1995; Talasz et al., 1996).
H1 is phosphorylated at a specific subset 
of sites during interphase
We  identified  interphase  phosphorylation  sites  in  HIC  frac-
tions from mid–S phase cells because H1 phosphorylation was 
clearly increasing at this time, but the chance of contamination 
by hyperphosphorylated H1 from mitotic cells was less than   
at later time points. SDS gel electrophoresis confirmed that the 
five major HIC peaks for mid–S phase samples were essentially 
homogenous fractions of H1.2 or H1.4 (Fig. S1 A). TDMS 
analyses of these fractions provided striking evidence that inter-
phase H1 phosphorylation is site specific. H1.2 contains four 
Cdk substrate motifs, but MS/MS analysis of the 1p-H1.2 peak 
localized phosphorylation exclusively to S173 in both allelic 
variants. Similarly, although H1.4 has five Cdk substrate motifs, 
interphase has recently been described, but direct evidence of 
its significance is lacking (Talasz et al., 2009).
Human somatic cells express six H1 variants with distinct 
chromatin-binding dynamics that possess CTDs differing in 
length, net charge, number, and relative positions of S/TPXK/R 
motifs (Hendzel et al., 2004; Th’ng et al., 2005). FRAP analyses 
of H1 mutated to mimic dephosphorylation or phosphorylation 
(Contreras et al., 2003; Hendzel et al., 2004) imply that phos-
phorylation is likely to have variant-specific and site-specific 
effects on H1 function, but the paucity of data on how H1 variant 
phosphorylation is regulated in vivo has hindered investigat-
ing this further. To address this problem, we characterized the 
phosphorylation  of  the  major  H1  variants  of  HeLa  S3  cells   
during interphase and mitosis and generated phosphorylation 
site–specific antisera to investigate the function of interphase 
H1 phosphorylation.
Results and discussion
The limited heterogeneity of H1 in  
HeLa cells
We used top-down mass spectrometry (MS [TDMS]) to analyze 
H1 phosphorylation because this approach facilitates character-
ization of multisite histone modification (Pesavento et al., 2008). 
The mass spectrum of crude H1 from asynchronous HeLa S3 
cells was remarkably simple, containing just seven distinct H1 
species (Fig. 1 A). A combination of analyses identified four of 
these to be unmodified and monophosphorylated allelic variants 
of H1.2 that are polymorphic for an Ala > Thr substitution at 
residue 142 (H1.2 [A142], H1.2 [T142], 1p-H1.2 [A142], and 
1p-H1.2 [T142]; Fig. S1 B and Fig. S2 F). The three remain-
ing forms correspond to unmodified, monophosphorylated, and 
diphosphorylated forms of H1.4 (H1.4, 1p-H1.4, and 2p-H1.4). 
Relative quantitation of the mass spectrum revealed that nearly 
a third of H1.2 and H1.4 is monophosphorylated, and roughly a 
sixth of H1.4 is diphosphorylated under these conditions. Small 
amounts of H1.5 were detected in crude H1 by TDMS, but we 
did not analyze these further. Additional H1 variants have been 
detected in HeLa cells previously (Garcia et al., 2004), but this 
is the first work demonstrating that HeLa S3 cells express pre-
dominantly H1.2 and H1.4 and that H1.2 is polymorphic in 
these cells.
To enhance phosphorylation site identification, we used 
hydrophobic interaction chromatography (HIC) to enrich phos-
phorylated forms of H1 before TDMS. HIC resolved five major 
peaks for crude H1 from asynchronous cells (Fig. 1 B). These 
correspond to the forms resolved by TDMS except that simi-
larly modified allelic variants of H1.2 were not separated from 
each other. The same HIC peaks were observed at all times 
sampled after cells were released from double-thymidine block 
synchronization (unpublished data), but the relative abundance 
of phosphorylated forms increased significantly as cells pro-
gressed toward mitosis. Phosphorylated H1.2 and H1.4 were 
more abundant in samples from mid–S phase cells (4 h after re-
lease) compared with asynchronous cells, and most H1.2 and 
H1.4 were tetra- and hexaphosphorylated, respectively, in cells 
arrested in mitosis with colchicine (Fig. 1 B). These findings are 
Figure 1.  The limited heterogeneity of H1 in HeLa cells. (A) The mass 
spectrum of intact crude H1 from asynchronous growing HeLa S3 cells. 
Proteins were identified directly by gas phase fragmentation and MS/MS 
analysis. Phosphorylation levels were inferred from predicted molecular 
masses. The A142T polymorphism in H1.2 was confirmed by genotyping 
(Fig. S1 B). (B) The HIC profiles of crude H1 from asynchronous grow-
ing, mid–S phase, and mitosis-arrested HeLa S3 cells. Eluate absorbance   
(214 nm) is plotted relative to time for equivalent portions of each separa-
tion. H1.2, H1.4, and H1.5 represent 47%, 48%, and 5% of total H1 in 
asynchronous cells, respectively, based on chromatographic integration.409 Transcription-associated H1 phosphorylation • Zheng et al.
pS173-H1.2 and pS187-H1.4 are enriched 
in nucleoli
To investigate the roles of specific H1 phosphorylations, we 
generated  antisera  against  phosphopeptides  containing  the 
pS173-H1.2 and pS187-H1.4 I sites and the pS27-H1.4 and 
pT154-H1.4 M sites (Fig. S2 A). We also generated antisera 
against recombinant human H1.4 that recognizes H1.4 regard-
less of its phosphorylation state to use as a control. The specific-
ity of these antisera was validated using Western blotting (Fig. S2, 
B–E), ELISA assays (not depicted), and immunocytochem-
istry (Fig. S3).
The pT154 antisera stained the chromosomes of mitotic 
HeLa cells intensely but did not stain interphase nuclei (Fig. 2 A). 
Similar results were observed for the pS27 and pT146 antisera 
(unpublished data), confirming that these sites are phosphory-
lated exclusively in mitosis. In contrast, the pS173 and pS187 
antisera stained chromatin in both interphase and mitotic cells. 
The pS173 antisera stained mitotic chromosomes less intensely 
than either the pT154 or the pS187 antisera. Because these 
residues are expected to be phosphorylated to similar degrees 
during mitosis, this suggests that the pS173 epitope may be 
less accessible in mitotic chromosomes. Differences were also 
observed for the staining of interphase cells by the pS173 and 
pS187 antisera (Fig. 2 A). Most interphase cells displayed stip-
pled nuclear staining and clusters of punctate nucleolar staining 
for pS173. Many interphase cells showed similar staining   
for pS187, but others displayed speckled staining similar to 
that of mouse 10T1/2 cells stained by antiserum to phosphory-
lated Tetrahymena thermophila H1. The latter antiserum pref-
erentially recognizes phosphorylated mouse H1.5, and it has   
been suggested that the speckled staining represents the local-
ization of transcriptionally active chromatin near sites of RNA   
splicing (Chadee et al., 1997). Other evidence suggests that 
speckled staining with this same antibody occurs primarily 
during G1 phase in human cells (Lu et al., 1994), but we have 
phosphorylation localized exclusively to S187 in the 1p-H1.4   
peak and to S172 plus S187 in the 2p-H1.4 peak (Table I,   
Fig. S1 B, and Fig. S2 F).
Analyses of the 4p-H1.2 and 6p-H1.4 peaks from colchicine- 
treated cells (Fig. 1 B) revealed uniform phosphorylation at   
the four and five Cdk substrate motifs present in H1.2 and 
H1.4, respectively (Table I and Fig. S2 F). A sixth site, S27, 
in an RKS motif that is unique to H1.4 was phosphorylated 
concurrently. We refer to T31, T146, and T154 of H1.2 and 
T18, S27, T146, and T154 of H1.4 as M sites because they 
appear to be phosphorylated exclusively during mitosis. In 
contrast, we refer to H1.2-S173, H1.4-S172, and H1.4-S187 as   
I sites because they can be phosphorylated during mitosis 
and interphase.
Our  results  suggest  that  H1.2-S173  and  H1.4-S172   
and -S187 are the sole sites of interphase phosphorylation in 
these proteins in human cells. Notably, monophosphorylation 
at H1.4-S172 was not detected, implying that interphase H1.4 
phosphorylation/dephosphorylation  occurs  hierarchically  or 
that other mechanisms prevent the accumulation of detect-
able H1.4-S172 monophosphorylation. Our findings also sug-
gest that interphase H1 kinases preferentially phosphorylate 
Ser-containing Cdk substrate motifs, which is consistent with 
evidence that three such sites in H1.5 are phosphorylated during   
interphase in human cells (Talasz et al., 2009). With the ex-
ception of H1.4-S27, all of the M sites identified in this study 
are  Thr-containing  Cdk  substrate  motifs.  Identification  of 
H1.4-S27 as an M site is noteworthy because phosphoryla-
tion at this residue during mitosis may affect acetylation or 
methylation at H1.4-K26 or the interaction of factors that rec-
ognize these modifications (Kuzmichev et al., 2004; Vaquero 
et al., 2004; Daujat et al., 2005; Trojer et al., 2007). We did 
not detect either modification at H1.4-K26 using TDMS, sug-
gesting that they affect <1% of total H1.4 in HeLa S3 cells 
(Pesavento et al., 2008).
Table I.  H1 phosphorylation during interphase and mitosis in HeLa S3 cells
HIC peak Molecular mass m Variant Modifications
Measured Predicted
D D
Interphase
1 21,491.6 21,332.8 +160 H1.4 pS172, pS187
2 21,412.3 21,332.8 +80 H1.4 pS187
3 21,333.1 21,332.8 0 H1.4 None
4 20,912.1 20,832.6 +80 H1.2 (A142) pS173
4 2,0941.7 20,832.6 +110 H1.2 (T142) pS173
5 20,832.3 20,832.6 0 H1.2 (A142) None
5 20,862.2 20,832.6 +30 H1.2 (T142) None
Mitosis
6p-H1.4 21,813.9 21,332.8 +480 H1.4 pT18, pS27, pT146, pT154, pS172, pS187
4p-H1.2 21,153.3 20,832.6 +320 H1.2 (A142) pT31, pT146, pT154, pS173
4p-H1.2 21,182.9 20,832.6 +350 H1.2 (T142) pT31, pT146, pT154, pS173
HIC peaks are labeled as in Fig. 1 B. Molecular masses are reported as neutral monoisotopic species. Predicted values were found using NCBI Protein database 
accession no. NP_005312 (H1.4) and NP_005310 (H1.2), assuming the loss of Met1 during protein maturation in vivo and residues 2–5 during electrospray ioniza-
tion. Peak identifications are based on MS/MS sequencing of multiple electron capture dissociation fragment ions. The A142 and T142 allelic variants of H1.2 were 
detected initially by MS and confirmed by genotyping as described in Fig. S1. Phosphorylated residues were identified by MS/MS sequencing of electron capture dis-
sociation fragment ions. Analyses of the H1.2 (T142) forms indicated that phosphorylated residues were identical to those determined for the H1.2 (A142) forms.JCB • VOLUME 189 • NUMBER 3 • 2010   410
ActD treatment that markedly reduced the levels of nascent 45S 
pre-rRNA  significantly  reduced  the  promoter  association  of 
pS187-H1.4 compared with untreated cells (Fig. 3, A and B). 
Although treatments that impair RNA pol II transcription are 
associated with global H1 dephosphorylation (Chadee et al., 
1997), immunoblots revealed that the limited ActD treatment 
used had little effect on the global levels of pS187-H1.4 and   
total H1.4 (Fig. 3 C). Moreover, ChIP with the -H1.4 antisera 
revealed that ActD treatment actually enhanced the level of total 
H1.4 at the promoter (Fig. 3 A). Collectively, the data suggest 
that pS187-H1.4 is enriched at active rDNA promoters and that 
this association is dynamically regulated.
The ultrastructural elements of nucleoli in higher eu-
karyotes, the fibrillar center (FC), the dense fibrillar compo-
nent (DFC), and the granular component, are thought to reflect 
vectorial organization of major steps in ribosome biogenesis: 
pre-rRNA transcription, pre-rRNA processing, and ribosome 
assembly on mature rRNA (Olson and Dundr, 2005; Hernandez-
Verdun, 2006). This organization is affected when rDNA tran-
scription is inhibited by ActD (Jordan et al., 1996; Olson and 
Dundr, 2005), so we investigated how ActD affects pS187-H1.4 
colocalization with markers for these nucleolar compartments. 
Fibrillarin localizes primarily to the DFC in punctate stain-
ing that rings FCs in untreated cells but becomes concentrated   
in large foci at the nucleolar periphery when the FC and DFC 
dissociate from each other in ActD-treated cells (Olson and 
Dundr,  2005). Although  pS187-H1.4  and  fibrillarin  colocal-
ized extensively in untreated cells, ActD caused a characteris-
tic change in this relationship (Fig. 3 D). Both proteins formed 
similar numbers of foci near the nucleolar periphery, but the 
pS187-H1.4 foci were typically smaller and shifted relative to 
the fibrillarin foci.
Similarly, pS187-H1.4 colocalized extensively with UBF 
in untreated cells (Fig. 3 D). ActD caused the characteristic 
punctate UBF staining to coalesce into a few large granules at the   
nucleolar periphery, which is in agreement with previous work 
(Zatsepina et al., 1993). However, in contrast to the fibrillarin 
not investigated whether this is the case for pS187 staining. In   
contrast, stippled staining distributed throughout interphase nuclei   
was observed for the -H1.4 antisera, with weaker staining asso-
ciated with nucleoli in some cases. Because this antiserum rec-
ognizes H1.4 regardless of its phosphorylation state (Fig. S2 D),   
the stippled pattern may reflect a nonuniform distribution of 
H1.4, as suggested previously for two H1 variants (Parseghian 
et al., 1994) or differences in the accessibility of H1.4 at different 
loci to the antisera.
Fibrillarin colocalized extensively with clustered punctate 
pS173 and pS187 staining, but not with -H1.4 staining, con-
firming that these H1.2/H1.4 phosphorylations are enriched in 
nucleoli (Fig. 2 B). Moreover, punctate pS187 staining colocal-
ized with centers of bromo-UTP (BrUTP) incorporation foci when 
cells were pulse labeled with BrUTP to detect nascent 45S pre–
ribosomal RNA (rRNA) transcripts (Fig. 2 C; Koberna et al., 
2002; Olson and Dundr, 2005). Similar results were obtained 
for pS173 staining (unpublished data), suggesting that inter-
phase phosphorylated H1.2/H1.4 are associated with transcrib-
ing rDNA (45S preribosomal RNA genes) and may facilitate 
RNA pol I transcription.
pS187-H1.4 is preferentially associated 
with active rDNA promoters
Mammalian cells contain several hundred rDNA repeats. The 
transcriptional  activity  of  individual  repeats  is  regulated  by 
mechanisms including histone modification to match cellular 
demand for ribosome biogenesis (Lawrence and Pikaard, 2004; 
Moss et al., 2007; McStay and Grummt, 2008). To investigate 
whether interphase H1 phosphorylation contributes to this regu-
lation, we used chromatin immunoprecipitation (ChIP) to com-
pare the association of pS187-H1.4 with rDNA promoters 
before and after selective inhibition of RNA pol I transcription 
with actinomycin D (ActD; Jordan et al., 1996; Olson and 
Dundr, 2005). The levels of 45S pre-rRNA were assessed using 
RT-PCR to provide a semiquantitative measure of rDNA tran-
scription (Huang et al., 2008; Murayama et al., 2008). A brief 
Figure 2.  Interphase phosphorylated H1.2/
H1.4  are  enriched  in  nucleoli.  (A)  Confocal   
images  of  asynchronous  HeLa  cells  stained 
with the H1 antisera shown. DNA was stained 
with TO-PRO-3. Arrows indicate mitotic cells. 
Bar, 20 µm. (B) Confocal images of asynchro-
nous  HeLa  cells  costained  with  antisera  to 
fibrillarin and the H1 antisera shown. Bars, 
5 µm. (C) Confocal images of asynchronous 
HeLa cells costained with antisera to pS187-
H1.4 and BrdU after pulse labeling with BrUTP 
to detect nascent transcripts. Bar, 5 µm. Plots of 
the relative fluorescence intensity of the green 
(pS187-H1.4) and red (BrUTP) channels along 
the white line shown in the merged panel dem-
onstrate  colocalization  of  pS187-H1.4  with 
BrUTP incorporation foci.411 Transcription-associated H1 phosphorylation • Zheng et al.
with UBF and RNA pol I before and after ActD treatment re-
ported in this study (Fig. 3) suggest the possibility that H1 ki-
nases are recruited to transcriptionally active/competent rDNA. 
S187 phosphorylation could promote rDNA decondensation 
and transcription by enhancing H1.4 dissociation and facilitat-
ing UBF binding.
Induced enrichment of pS187-H1.4 at 
hormone response elements
Data from approaches that do not account for H1 phosphorylation   
suggest that H1 represses transcription by RNA pol II (Laybourn 
and Kadonaga, 1991; Cheung et al., 2002; Lee et al., 2004; Kim 
et al., 2008). In contrast, ChIP analyses using antisera to phos-
phorylated T. thermophila H1 suggest that H1 phosphorylation 
is required for glucocorticoid-dependent transcription from the 
murine mammary tumor virus (MMTV) promoter in mamma-
lian cells (Lee and Archer, 1998; Bhattacharjee et al., 2001). 
This led us to investigate whether pS187-H1.4 is involved in 
transcription by RNA pol II.
We used ChIP to compare the association of pS187-H1.4 
with the multicopy MMTV long terminal repeat glucocorticoid 
response element (GRE [MMTV-GRE]) in murine 3134 mam-
mary tumor cells before and after hormone stimulation. Dexa-
methasone rapidly induced pS187-H1.4 association with the 
MMTV-GRE, increasing the level of pS187-H1.4 at this locus by 
approximately threefold in 60 min (Fig. 4 A). Rapid, hormone- 
induced enrichment of pS187-H1.4 was also observed at the 
results, UBF and pS187-H1.4 foci colocalized completely in 
ActD-treated cells. ActD had similar effects on the colocal-
ization of pS187-H1.4 and RNA pol I (RPA 194). Like UBF, 
RPA 194 localizes preferentially to the FC in untreated cells 
(Matera et al., 1994). Punctate pS187-H1.4 and RPA 194 stain-
ing colocalized extensively in the central portions of nucleoli 
in untreated cells, and they colocalized completely in dense 
clusters at the edge of nucleoli in ActD-treated cells (Fig. 3 D). 
The perdurance of pS187-H1.4 staining and its colocalization 
with UBF and RPA 194 in foci formed upon ActD treatment are 
consistent with evidence that the latter proteins remain associ-
ated with rDNA under these conditions (Jordan et al., 1996). 
Together, these results suggest that pS187-H1.4 is enriched in 
active rDNA within the FC or at the FC–DFC interface in un-
treated cells.
UBF dimers bind rDNA promoters and activate transcrip-
tion by recruiting SL1/TIF-IB and enhancing preinitiation com-
plex formation (Moss et al., 2007; McStay and Grummt, 2008). 
UBF binding throughout the transcribed portions of rDNA re-
peats may also affect other aspects of RNA pol I transcription 
and help maintain the euchromatic state of rDNA (O’Sullivan 
et al., 2002; Moss et al., 2007; Sanij et al., 2008; Sanij and   
Hannan, 2009). Multiple lines of evidence suggest that compe-
tition between UBF and H1 determines the proportion of active 
rDNA repeats (Kermekchiev et al., 1997; Sanij et al., 2008). 
The dependence of pS187-H1.4 and rDNA promoter association 
on RNA pol I activity and the colocalization of pS187-H1.4   
Figure 3.  pS187-H1.4 is preferentially associated with transcriptionally active rDNA. (A) The levels of pS187-H1.4 and total H1.4 (-H1.4) at the 45S pre-
rRNA promoter in untreated and 50 ng/ml ActD-treated HeLa cells (3 h). The data are expressed as fold change relative to a parallel ChIP without primary 
antibody from untreated cells. (B) The levels of the 45S pre-rRNA transcript in untreated and ActD-treated cells were assayed by RT-PCR and normalized to 
-actin expression. The data in A and B represent the mean of two independent experiments. Error bars indicate the standard error of the mean for triplicate 
samples. (C) The global levels of pS187-H1.4 and total H1.4 in ActD-treated cells were assayed by immunoblotting and quantified relative to the control 
samples after normalization to -tubulin levels. MW, molecular weight. (D) Confocal images of control and ActD-treated HeLa cells costained with antibodies 
to pS187-H1.4 and fibrillarin, UBF, or the large subunit of RNA polymerase I (RPA 194). DNA was visualized using TO-PRO-3. Bars, 5 µm.JCB • VOLUME 189 • NUMBER 3 • 2010   412
at a limited number of specific sites enables H1 to affect chroma-
tin accessibility to factors that regulate transcription and other 
processes. Our evidence that the association of pS187-H1.4 with 
specific loci is dynamic implies that H1 kinases and phospha-
tases are recruited to these loci in a targeted fashion, although 
little is known about the mechanisms involved. Kinases that me-
diate interphase H1 phosphorylation in vivo have not been di-
rectly identified, but several lines of evidence implicate Cdk2 
(Herrera et al., 1996; Bhattacharjee et al., 2001; Contreras et al., 
2003). Less is known about whether specific phosphatases regu-
late interphase H1 phosphorylation. Although our data support 
the general model that interphase phosphorylation enhances H1 
dissociation from chromatin, variation in the numbers, locations, 
and structures of I sites among H1 variants suggests that inter-
phase phosphorylation may affect H1 chromatin binding in a 
variant-specific fashion. Such differences may underlie recent 
evidence for H1 variant–specific effects on transcription and rep-
lication (Sancho et al., 2008; Talasz et al., 2009).
Materials and methods
Cell culture
HeLa S3 cells were grown in suspension in Joklik’s modified minimal essential 
medium supplemented with 10% newborn calf serum (NCS) and synchro-
nized using the double-thymidine block procedure as described previously 
(Pesavento et al., 2008). 1 µM colchicine was added to growing asynchro-
nous cells for 18 h to enrich for mitotic cells. For the experiments shown in   
Fig. 3, adherent HeLa cells were grown in DME supplemented with 10% FBS. 
Cells were treated with 0.05 µg/ml ActD for 3 h to selectively inhibit 
RNA pol I transcription. 3134 cells were maintained in DME supplemented 
with 10% FBS, sodium pyruvate, nonessential amino acids, and 2 mM gluta-
mine as described previously (John et al., 2009). Cells were transferred to 
DME supplemented with 10% charcoal dextran–treated FBS for 48 h before 
treatment with 100 nM dexamethasone. MCF-7 cells were maintained in DME 
supplemented with 5% NCS as described previously (Schultz-Norton et al., 
2007). Cells were transferred to phenol red–free DME containing 5% charcoal 
dextran–treated NCS for 72–96 h before treatment with 10 nM estradiol.
Histone preparation, chromatography, and MS
Crude  H1  was  prepared  by  5%  perchloric  acid  fractionation  of  crude   
histones (Pesavento et al., 2008). Recombinant human H1.4 was expressed in 
Escherichia coli BL21 cells from a pET-3d vector using standard procedures.
single-copy Sgk gene GRE in these same cells (Fig. 4 B). We 
also compared how the association of pS187-H1.4 and estrogen 
receptor– (ER-) with the estrogen response element (ERE) of 
the pS2 gene in MCF-7 human breast cancer cells changes after 
estradiol treatment (Fig. 4 C). Both ER- and pS187-H1.4 were 
markedly enriched at the pS2-ERE after just 15 min of estradiol   
treatment and became further enriched after 45 min of treat-
ment. Collectively, the data in Fig. 4 suggest that H1.4-S187 phos-
phorylation facilitates gene-specific activation of RNA pol II 
transcription by nuclear hormone receptors.
Analyses of glucocorticoid receptor–regulated transcrip-
tion at the MMTV promoter in different systems suggest that 
H1 is depleted immediately after hormone stimulation (Bresnick 
et al., 1992; Belikov et al., 2007) but reassociates with refrac-
tory promoters after prolonged hormone treatment (Lee and   
Archer, 1998), which is consistent with the notion that H1 gen-
erally acts as a repressor. In contrast, overexpression of H1c or 
H1° enhanced basal and hormone-stimulated transcription of 
stably integrated MMTV-LTR reporter genes in murine 3T3 
cells and prevented their repression during prolonged hormone 
stimulation (Gunjan and Brown, 1999). Our data are consistent 
with the proposal that H1 affects MMTV promoter chromatin 
architecture to facilitate the binding of liganded nuclear hor-
mone receptors, their synergism with transcription factors such 
as NF1 and AP-1, and the recruitment or activation of kinases 
that phosphorylate and facilitate H1 displacement after hor-
mone stimulation (Vicent et al., 2002). Together with recent evi-
dence that estradiol stimulates the exchange of HMGB for H1 
at the pS2-ERE and sites recognized by AP-1 or by other nu-
clear hormone receptors (Ju et al., 2006), our data suggest that 
H1.4-S187 phosphorylation promotes transcriptional activation 
by nuclear hormone receptors by enhancing chromatin access 
for other regulatory factors.
Considered together with evidence from FRAP analyses 
that mutations mimicking phosphorylation or dephosphorylation 
of Cdk sites enhance or diminish H1-GFP dissociation from 
chromatin, respectively, our findings imply that phosphorylation 
Figure  4.  Hormone-induced  enrichment  of 
pS187-H1.4 at nuclear hormone receptor re-
sponse elements. (A) pS187-H1.4 association 
with the MMTV-GRE in 3134 cells before and 
after  dexamethasone  treatment.  (B)  pS187-
H1.4 association with the Sgk gene GRE in 
3134 cells before and after dexamethasone 
treatment.  (C)  ER-  and  pS187-H1.4  asso-
ciation with the pS2 gene ERE in MCF-7 cells 
before and after estradiol treatment. The data 
are normalized to the signal obtained for each 
antibody before hormone treatment and rep-
resent  the  mean  of  two  independent  experi-
ments. Error bars indicate the standard error 
of the mean for triplicate samples.413 Transcription-associated H1 phosphorylation • Zheng et al.
10 mM Tris-HCl, pH 8.0, and twice with 1 mM EDTA and 10 mM Tris-HCl, 
pH 8.0. Beads were eluted twice with 200 µl 1% SDS in 0.1 M NaHCO3 
at 65°C for 10 min. The combined eluates were made 200 mM NaCl 
(final), incubated at 65°C overnight to reverse cross-links, digested with 
50 µg/ml RNase A at 37°C for 30 min, and then digested with 50 µg/ml   
proteinase K at 50°C for 1 h. The DNA fragments were then purified by 
phenol/chloroform extraction, recovered by ethanol precipitation using   
20 µg glycogen as a carrier, and dissolved in 50 µl of deionized water.
ChIP  products  were  quantitated  by  real-time  PCR  using  SYBR 
Green  master  mix  (Applied  Biosystems)  and  the  following  primers: 
rRNA promoter (forward), 5-GTGGCTGCGATGGTGGCGTTTT-3 and 
(reverse) 5-TGCCGACTCGGAGCGAAAGA-3; MMTV-GRE (forward), 
5-TTTCCATACCAAGGAGGGGACAGTG-3 and (reverse) 5-CTTACT-
TAAGCCTTGGGAACCGCAA-3; Sgk-GRE (forward), 5-CTTCCCTTAT-
CCAGCATGTCTTGTG-3 and (reverse) 5-TGCATCGTGCAATCTGTGGC-3; 
and  pS2-ERE  (forward),  5-CCCGTGAGCCACTGTTGTC-3  and  (reverse) 
5-CCTCCCGCCAGGGTAAATAC-3.
ChIP to monitor the association of ER- and pS187-H1.4 with the 
pS2-ERE included minor modifications as described previously (Schultz- 
Norton et al., 2007). The ER- antibody (sc-8002) for ChIP was obtained 
from Santa Cruz Biotechnology, Inc.
Online supplemental material
Fig. S1 shows SDS gel and TDMS analyses of H1 fractions with different 
levels of phosphorylation prepared from mid–S phase HeLa cells using HIC. 
Fig. S2 shows the specificity of antisera for individual H1 phosphorylation 
sites, the antisera to total H1.4 in immunoblots, and the phosphorylation 
sites identified in this study relative to an alignment of the human H1.1–
H1.5 protein sequences. Fig. S3 shows the specificity of the pS173-H1.2 
and pS187-H1.4 antisera using peptide competition in immunofluorescence 
microscopy.  Online  supplemental  material  is  available  at  http://www.jcb 
.org/cgi/content/full/jcb.201001148/DC1.
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